Evidence map›Paper›PMID 32691362›Full record

ArticleTherapeutic innovation & regulatory science2020

Evaluation of the Content Validity and Cross-Cultural Validity of the Study Participant Feedback Questionnaire (SPFQ).

Alison Greene, Mary Elmer, Sean Ludlam, Kathyjo Shay, Sarah Bentley, Claire Trennery, Rebecca Grimes, Adam Gater

Open access · hybridAbstract read
In one paragraph

Article in Therapeutic innovation & regulatory science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Alison GreenePatient-Centered Outcomes Research, Genentech, San Francisco, CA, 94080, USA.
Mary ElmerMerck & Co., Inc., Upper Gwynedd, PA, 19446, USA.
Sean LudlamClinical Records Management, Allergan, Madison, NJ, 07940, USA.
Kathyjo ShayClinical Science Center of Excellence, Astellas Pharma Global Development, Inc., Northbrook, IL, 60062, USA.
Sarah BentleyPatient-Centered Outcomes, Adelphi Values, Bollington, SK10 5JB, UK. sarah.bentley@adelphivalues.com.
Claire TrenneryPatient-Centered Outcomes, Adelphi Values, Bollington, SK10 5JB, UK.
Rebecca GrimesPatient-Centered Outcomes, Adelphi Values, Bollington, SK10 5JB, UK.
Adam GaterPatient-Centered Outcomes, Adelphi Values, Bollington, SK10 5JB, UK.
Adelphi Group (United Kingdom) · GBAllergan (United States) · USAstellas Pharma (United States) · USGwynedd Mercy University · USPatient-Centered Outcomes Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe Study Participant Feedback Questionnaire (SPFQ) is a patient-completed tool designed to assess patient experiences and satisfaction with aspects associated with being involved in a clinical trial. Originally developed in oncology and among English-speaking participants, the aim of the current study was to evaluate the content and cross-cultural validity of the SPFQ in other indications and non-English-speaking countries.

methodsSemi-structured qualitative telephone interviews were conducted with 80 participants across eight non-English-speaking countries (in Europe, South America and Asia) who had received an investigational medicinal product as part of a clinical trial in the past three years. Interviews comprised concept elicitation to identify concepts of importance to participants' trial experiences, and cognitive debriefing to assess understanding and perceived importance of SPFQ instructions, items and response options.

resultsConcept elicitation findings supported the content validity of the SPFQ. During cognitive debriefing, SPFQ instructions and the majority of items were well understood by participants. Participants generally considered the SPFQ items important to their clinical trial experience, albeit a handful of items assessed concepts that had not been experienced by trial participants or were redundant with other SPFQ items. The instructions, response options and recall period of the SPFQ were generally well understood. No country-level differences in understanding or importance were apparent.

conclusionStudy findings provide evidence for the content and cross-cultural validity of the SPFQ and support implementation of the SPFQ as a means of obtaining participant feedback across global development programmes in a variety of indications.

Indexed as

Cross-Cultural ComparisonAdultAgedAsiaEuropeFeedbackFemaleHumansMaleMiddle AgedSurveys and QuestionnairesClinical trial feedbackCross-cultural validityPatient experienceQualitative researchSPFQ

Identifiers

PMID32691362
PMCPMC7704515
OpenAlexW3045239416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.